CDH2 and lung adenocarcinoma: Low FBXO11 expression in lung adenocarcinoma cells increases ZEB1 protein levels, decreases epithelial marker E-cadherin, and increases mesenchymal markers N-cadherin and vimentin, promoting EMT and enhancing cell migration and invasion.